Choose Your Money-Saving Mounjaro 5mg Bundle
Progress Duo Bundle - Best Value for 5mg Users
Our Progress Duo Bundle combines Mounjaro 5mg with 7.5mg for seamless dose progression. At £369.99 for first orders (£409.99 returning customers), you save £40 compared to buying these prescription-only pens separately. This bundle suits those who've completed their initial 2.5mg dose and are ready to progress through 5mg to 7.5mg over 8 weeks.
Progress Trio Bundle - Maximum Savings
Save £65 with our Progress Trio Bundle featuring 5mg, 7.5mg, and 10mg pens for £634.99 (first order) or £674.99 for returning customers. This comprehensive bundle provides 12 weeks of treatment, taking you from the 5mg maintenance phase through to the higher 10mg dose. Perfect for those committed to their full treatment journey.
Intro Duo Bundle - Starting Your Journey
New to Mounjaro? Our Intro Duo Bundle pairs 2.5mg with 5mg for £299.99 (first order). This bundle may help you transition smoothly from the initial starter dose to the 5mg maintenance level. Each pen provides 4 weekly injections, giving you 8 weeks of treatment alongside your reduced-calorie diet and exercise programme.
Why Choose EverydayMeds Bundles?
Every Mounjaro bundle includes comprehensive clinical assessment by our GPhC-registered pharmacists. Your prescription-only medication arrives with free UK delivery, detailed injection guides, and ongoing support. We're MHRA-compliant and offer both standard 3-day approval and express 24-hour processing for urgent orders.
First Order Savings
New customers save an additional £40 with code FIRST40, making our Progress Duo just £329.99 and Progress Trio only £594.99. Combined with our bundle savings, first-time buyers can save up to £105 compared to individual pen purchases. This prescription-only treatment requires clinical assessment, but approval typically takes just 3 working days.
Order your Mounjaro 5mg bundle today and start your weight management journey with the UK's trusted online pharmacy. Express approval available for faster treatment access.
